Yu. V. Mareev

1.1k total citations
40 papers, 254 citations indexed

About

Yu. V. Mareev is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Neurology. According to data from OpenAlex, Yu. V. Mareev has authored 40 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 9 papers in Infectious Diseases and 8 papers in Neurology. Recurrent topics in Yu. V. Mareev's work include Heart Failure Treatment and Management (13 papers), Cardiac pacing and defibrillation studies (10 papers) and COVID-19 Clinical Research Studies (9 papers). Yu. V. Mareev is often cited by papers focused on Heart Failure Treatment and Management (13 papers), Cardiac pacing and defibrillation studies (10 papers) and COVID-19 Clinical Research Studies (9 papers). Yu. V. Mareev collaborates with scholars based in Russia, Tajikistan and United Kingdom. Yu. V. Mareev's co-authors include Mareev VIu, John G.F. Cleland, Yu. L. Begrambekova, Yа. A. Orlova, Е.П. Павликова, С.Т. Мацкеплишвили, L. М. Samokhodskaya, В. Е. Синицын, А. А. Гарганеева and Е. А. Мершина and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and Clinical Therapeutics.

In The Last Decade

Yu. V. Mareev

34 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu. V. Mareev Russia 11 159 68 48 35 19 40 254
Yu. L. Begrambekova Russia 8 61 0.4× 63 0.9× 44 0.9× 23 0.7× 19 1.0× 34 154
Ranu Baral United Kingdom 7 92 0.6× 126 1.9× 79 1.6× 13 0.4× 21 1.1× 14 269
Rossella Morandini Italy 6 241 1.5× 121 1.8× 68 1.4× 33 0.9× 10 0.5× 9 389
Tyler J Gluckman United States 9 144 0.9× 38 0.6× 34 0.7× 22 0.6× 7 0.4× 22 271
Ashish Correa United States 11 123 0.8× 45 0.7× 19 0.4× 22 0.6× 35 1.8× 31 289
Abraham Oomman India 10 213 1.3× 18 0.3× 22 0.5× 53 1.5× 25 1.3× 45 331
Kevin Levitt Canada 5 160 1.0× 90 1.3× 46 1.0× 23 0.7× 54 2.8× 9 311
Antoine Fayol France 10 138 0.9× 76 1.1× 44 0.9× 12 0.3× 15 0.8× 22 250
Gurpreet Johal United States 10 108 0.7× 25 0.4× 13 0.3× 47 1.3× 30 1.6× 30 274
Daan J.L. van Twist Netherlands 10 94 0.6× 46 0.7× 33 0.7× 14 0.4× 13 0.7× 34 227

Countries citing papers authored by Yu. V. Mareev

Since Specialization
Citations

This map shows the geographic impact of Yu. V. Mareev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu. V. Mareev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu. V. Mareev more than expected).

Fields of papers citing papers by Yu. V. Mareev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu. V. Mareev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu. V. Mareev. The network helps show where Yu. V. Mareev may publish in the future.

Co-authorship network of co-authors of Yu. V. Mareev

This figure shows the co-authorship network connecting the top 25 collaborators of Yu. V. Mareev. A scholar is included among the top collaborators of Yu. V. Mareev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu. V. Mareev. Yu. V. Mareev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mareev, Yu. V., М. В. Ежов, S. V. Villevalde, et al.. (2023). Cardiovascular effects of omega-3 polyunsaturated fatty acids: position of omega-3 polyunsaturated fatty acids in Russian and international guidelines. Council of Experts. Kardiologiia. 63(2). 11–18. 2 indexed citations
2.
Mareev, Yu. V., М. М. Lukyanov, S. Yu. Martsevich, et al.. (2023). Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization. CARDIOVASCULAR THERAPY AND PREVENTION. 21(12). 3437–3437. 1 indexed citations
3.
Mareev, Yu. V., et al.. (2022). Cardiac contractility modulation in heart failure with reduced ejection fraction treatment. Kardiologiia. 62(11). 71–78. 1 indexed citations
4.
Mareev, Yu. V., Yu. L. Begrambekova, Yu. M. Lopatin, et al.. (2021). Expert consensus regarding treatment of iron deficiency in stable and decompensated patients with heart failure. Kardiologiia. 61(4). 73–78. 5 indexed citations
6.
VIu, Mareev, et al.. (2021). Effect of 24-hour blood pressure and heart rate on the prognosis of patients with reduced and midrange LVEF. Kardiologiia. 61(7). 4–13. 1 indexed citations
7.
VIu, Mareev, Yа. A. Orlova, Е.П. Павликова, et al.. (2020). Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT). Kardiologiia. 60(11). 4–15. 18 indexed citations
9.
Mareev, Yu. V., et al.. (2019). Telemonitoring in patients with chronic heart failure. Kardiologiia. 59(9S). 4–15. 11 indexed citations
11.
Mareev, Yu. V. & Mareev VIu. (2017). Characteristics and treatment of hospitalized patients with CHF. Kardiologiia. 17(S4). 20–30. 15 indexed citations
13.
Cleland, John G.F., Michele Robertson, Ian Ford, et al.. (2017). 246Effect of Ivabradine on Mortality in Patients with heart failure and a reduced left ventricular ejection fraction not receiving a beta-blocker: an analysis from SHIFT. European Heart Journal. 38(suppl_1). 2 indexed citations
14.
Mareev, Yu. V.. (2015). Cardiac contractility modulation in treatment of patients with chronic heart failure. SHILAP Revista de lepidopterología. 18(4). 158–158. 2 indexed citations
15.
Mareev, Yu. V., et al.. (2015). Cardiac Resynchronization Therapy Update: Evolving Indications, Expanding Benefit?. Current Cardiology Reports. 17(10). 90–90. 2 indexed citations
16.
Mareev, Yu. V. & John G.F. Cleland. (2015). Should β-Blockers Be Used in Patients With Heart Failure and Atrial Fibrillation?. Clinical Therapeutics. 37(10). 2215–2224. 33 indexed citations
17.
VIu, Mareev & Yu. V. Mareev. (2015). Methods of Prevention of Sudden Death in Chronic Heart Failure. Kardiologiia. 9_2015(9). 72–83. 1 indexed citations
18.
Mironov, N. Yu., Yu. V. Mareev, Н. Б. Шлевков, et al.. (2015). Ventricular Tachycardia as a First Manifestation of Myotonic Dystrophy. Kardiologiia. 8_2015(8). 86–96.
19.
Mironov, N. Yu., et al.. (2012). [Electrophysiological effects and antiarrhythmic activity of novel domestic class III antiarrhythmogenic drug niferidil administered in patients with paroxismal supraventricular tachycardia].. PubMed. 75(10). 16–21. 2 indexed citations
20.
Mareev, Yu. V., et al.. (2011). [Antitachycardia and resynchronization devices in the treatment of heart failure and prevention of sudden death].. PubMed. 51(9). 60–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026